JILL DANA: Open Payments
NPI 1063184869 · AVON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,235 in 96 payments from 16 companies in 2025. Trend: 2023 $188 · 2024 $1,743 · 2025 $2,235
Food & beverage: $2,235
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $397 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $259 |
| Janssen Biotech, Inc. | 11 | $232 |
| Lilly USA, LLC | 6 | $165 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $165 |
| Madrigal Pharmaceuticals | 3 | $161 |
| Ardelyx, Inc. | 5 | $146 |
| Gilead Sciences, Inc. | 6 | $141 |
| Regeneron Healthcare Solutions, Inc. | 4 | $103 |
| QOL Medical, LLC | 5 | $99 |
Products named: ENTYVIO, TREMFYA, OMVOH, XIFAXAN, REZDIFFRA, IBSRELA, CREON, DUPIXENT.
Industry payments across IN — which companies pay providers there.
